Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Neoplasms of the CNS

  Free Subscription


Articles published in J Neuropathol Exp Neurol

Retrieve available abstracts of 51 articles:
HTML format
Text format



Single Articles


    November 2017
  1. SHI QY, Feng X, Bao W, Ma J, et al
    MYC/BCL2 Co-Expression Is a Stronger Prognostic Factor Compared With the Cell-of-Origin Classification in Primary CNS DLBCL.
    J Neuropathol Exp Neurol. 2017;76:942-948.
    PubMed     Text format     Abstract available


    October 2017
  2. FOO ASC, Tan DTM, Tan CL, Sahm F, et al
    Report of a Novel Case of Anaplastic Olfactory Groove Meningioma and Its Methylation Subtype.
    J Neuropathol Exp Neurol. 2017 Oct 16. doi: 10.1093.
    PubMed     Text format     Abstract available


  3. HANNEN R, Hauswald M, Bartsch JW
    A Rationale for Targeting Extracellular Regulated Kinases ERK1 and ERK2 in Glioblastoma.
    J Neuropathol Exp Neurol. 2017;76:838-847.
    PubMed     Text format     Abstract available


  4. FORSSTROM LM, Sumi K, Makinen MJ, Oh JE, et al
    Germline MSH6 Mutation in a Patient With Two Independent Primary Glioblastomas.
    J Neuropathol Exp Neurol. 2017;76:848-853.
    PubMed     Text format     Abstract available


  5. RICHARDSON TE, Shen ZJ, Kanchwala M, Xing C, et al
    Aggressive Behavior in Silent Subtype III Pituitary Adenomas May Depend on Suppression of Local Immune Response: A Whole Transcriptome Analysis.
    J Neuropathol Exp Neurol. 2017;76:874-882.
    PubMed     Text format     Abstract available


    September 2017
  6. DONSON AM, Apps J, Griesinger AM, Amani V, et al
    Molecular Analyses Reveal Inflammatory Mediators in the Solid Component and Cyst Fluid of Human Adamantinomatous Craniopharyngioma.
    J Neuropathol Exp Neurol. 2017;76:779-788.
    PubMed     Text format     Abstract available


    August 2017
  7. SCHWEIZER Y, Meszaros Z, Jones DTW, Koelsche C, et al
    Molecular Transition of an Adult Low-Grade Brain Tumor to an Atypical Teratoid/Rhabdoid Tumor Over a Time-Course of 14 Years.
    J Neuropathol Exp Neurol. 2017;76:655-664.
    PubMed     Text format     Abstract available


  8. PRATT D, Pittaluga S, Palisoc M, Fetsch P, et al
    Expression of CD70 (CD27L) Is Associated With Epithelioid and Sarcomatous Features in IDH-Wild-Type Glioblastoma.
    J Neuropathol Exp Neurol. 2017;76:697-708.
    PubMed     Text format     Abstract available


    July 2017
  9. RYALL S, Arnoldo A, Krishnatry R, Mistry M, et al
    Multiplex Detection of Pediatric Low-Grade Glioma Signature Fusion Transcripts and Duplications Using the NanoString nCounter System.
    J Neuropathol Exp Neurol. 2017;76:562-570.
    PubMed     Text format     Abstract available


  10. AMANI V, Donson AM, Lummus SC, Prince EW, et al
    Characterization of 2 Novel Ependymoma Cell Lines With Chromosome 1q Gain Derived From Posterior Fossa Tumors of Childhood.
    J Neuropathol Exp Neurol. 2017;76:595-604.
    PubMed     Text format     Abstract available


    May 2017
  11. BARRESI V, Caffo M
    Rhabdoid Meningioma: Grading and Prognostic Significance of This Uncommon Variant.
    J Neuropathol Exp Neurol. 2017;76:414-416.
    PubMed     Text format    


    April 2017
  12. BARRESI V, Lionti S, Valori L, Gallina G, et al
    Dual-Genotype Diffuse Low-Grade Glioma: Is It Really Time to Abandon Oligoastrocytoma As a Distinct Entity?
    J Neuropathol Exp Neurol. 2017 Apr 17. doi: 10.1093.
    PubMed     Text format     Abstract available


  13. AMES H, Halushka MK, Rodriguez FJ
    miRNA Regulation in Gliomas: Usual Suspects in Glial Tumorigenesis and Evolving Clinical Applications.
    J Neuropathol Exp Neurol. 2017;76:246-254.
    PubMed     Text format     Abstract available


    March 2017
  14. BOULAGNON-ROMBI C, Fleury C, Fichel C, Lefour S, et al
    Immunohistochemical Approach to the Differential Diagnosis of Meningiomas and Their Mimics.
    J Neuropathol Exp Neurol. 2017 Mar 14. doi: 10.1093.
    PubMed     Text format     Abstract available


  15. BALLESTER LY, Fuller GN, Powell SZ, Sulman EP, et al
    Retrospective Analysis of Molecular and Immunohistochemical Characterization of 381 Primary Brain Tumors.
    J Neuropathol Exp Neurol. 2017;76:179-188.
    PubMed     Text format     Abstract available


  16. BRUNER JM, Louis DN, McLendon R, Rosenblum MK, et al
    The Utility of Expert Diagnosis in Surgical Neuropathology: Analysis of Consultations Reviewed at 5 National Comprehensive Cancer Network Institutions.
    J Neuropathol Exp Neurol. 2017;76:189-194.
    PubMed     Text format     Abstract available


    January 2017
  17. ROBINSON C, Kleinschmidt-DeMasters BK
    IDH1-Mutation in Diffuse Gliomas in Persons Age 55 Years and Over.
    J Neuropathol Exp Neurol. 2017 Jan 21. pii: nlw112. doi: 10.1093.
    PubMed     Text format     Abstract available


  18. GOSCHZIK T, Gessi M, Dreschmann V, Gebhardt U, et al
    Genomic Alterations of Adamantinomatous and Papillary Craniopharyngioma.
    J Neuropathol Exp Neurol. 2017 Jan 9. pii: nlw116. doi: 10.1093.
    PubMed     Text format     Abstract available


  19. ASSLABER M, Schauer S, Gogg-Kamerer M, Bernhart E, et al
    Native Oligodendrocytes in Astrocytomas Might Inhibit Tumor Proliferation by WIF1 Expression.
    J Neuropathol Exp Neurol. 2017;76:16-26.
    PubMed     Text format     Abstract available


  20. JAPP AS, Klein-Hitpass L, Denkhaus D, Pietsch T, et al
    OTX2 Defines a Subgroup of Atypical Teratoid Rhabdoid Tumors With Close Relationship to Choroid Plexus Tumors.
    J Neuropathol Exp Neurol. 2017;76:32-38.
    PubMed     Text format     Abstract available


    November 2016
  21. YUAN JX, Bafakih FF, Mandell JW, Horton BJ, et al
    Quantitative Analysis of the Cellular Microenvironment of Glioblastoma to Develop Predictive Statistical Models of Overall Survival.
    J Neuropathol Exp Neurol. 2016.
    PubMed     Text format     Abstract available


  22. LING C, Pouget C, Rech F, Pflaum R, et al
    Endothelial Cell Hypertrophy and Microvascular Proliferation in Meningiomas Are Correlated with Higher Histological Grade and Shorter Progression-Free Survival.
    J Neuropathol Exp Neurol. 2016.
    PubMed     Text format     Abstract available


    August 2016
  23. WOOD MD, Reis GF, Reuss DE, Phillips JJ, et al
    Protein Analysis of Glioblastoma Primary and Posttreatment Pairs Suggests a Mesenchymal Shift at Recurrence.
    J Neuropathol Exp Neurol. 2016.
    PubMed     Text format     Abstract available


  24. GRAHAM CD, Kaza N, Klocke BJ, Gillespie GY, et al
    Tamoxifen Induces Cytotoxic Autophagy in Glioblastoma.
    J Neuropathol Exp Neurol. 2016.
    PubMed     Text format     Abstract available


    June 2016
  25. FONTANA L, Tabano S, Bonaparte E, Marfia G, et al
    MGMT-Methylated Alleles Are Distributed Heterogeneously Within Glioma Samples Irrespective of IDH Status and Chromosome 10q Deletion.
    J Neuropathol Exp Neurol. 2016.
    PubMed     Text format     Abstract available


    May 2016
  26. DICKINSON PJ, York D, Higgins RJ, LeCouteur RA, et al
    Chromosomal Aberrations in Canine Gliomas Define Candidate Genes and Common Pathways in Dogs and Humans.
    J Neuropathol Exp Neurol. 2016.
    PubMed     Text format     Abstract available


    April 2016
  27. KLEINSCHMIDT-DEMASTERS BK, Donson AM, Richmond AM, Pekmezci M, et al
    SOX10 Distinguishes Pilocytic and Pilomyxoid Astrocytomas From Ependymomas but Shows No Differences in Expression Level in Ependymomas From Infants Versus Older Children or Among Molecular Subgroups.
    J Neuropathol Exp Neurol. 2016;75:295-8.
    PubMed     Text format     Abstract available


  28. ROTH JJ, Fierst TM, Waanders AJ, Yimei L, et al
    Whole Chromosome 7 Gain Predicts Higher Risk of Recurrence in Pediatric Pilocytic Astrocytomas Independently From KIAA1549-BRAF Fusion Status.
    J Neuropathol Exp Neurol. 2016;75:306-15.
    PubMed     Text format     Abstract available


  29. HEILAND DH, Staszewski O, Hirsch M, Masalha W, et al
    Malignant Transformation of a Dysembryoplastic Neuroepithelial Tumor (DNET) Characterized by Genome-Wide Methylation Analysis.
    J Neuropathol Exp Neurol. 2016;75:358-65.
    PubMed     Text format     Abstract available


    March 2016
  30. A DZAYE OD, Hu F, Derkow K, Haage V, et al
    Glioma Stem Cells but Not Bulk Glioma Cells Upregulate IL-6 Secretion in Microglia/Brain Macrophages via Toll-like Receptor 4 Signaling.
    J Neuropathol Exp Neurol. 2016.
    PubMed     Text format     Abstract available


  31. SUWALA AK, Hanaford A, Kahlert UD, Maciaczyk J, et al
    Clipping the Wings of Glioblastoma: Modulation of WNT as a Novel Therapeutic Strategy.
    J Neuropathol Exp Neurol. 2016.
    PubMed     Text format     Abstract available


  32. NEUMANN JE, Dorostkar MM, Korshunov A, Mawrin C, et al
    Distinct Histomorphology in Molecular Subgroups of Glioblastomas in Young Patients.
    J Neuropathol Exp Neurol. 2016.
    PubMed     Text format     Abstract available


  33. FRITCHIE KJ, Jin L, Rubin BP, Burger PC, et al
    NAB2-STAT6 Gene Fusion in Meningeal Hemangiopericytoma and Solitary Fibrous Tumor.
    J Neuropathol Exp Neurol. 2016;75:263-71.
    PubMed     Text format     Abstract available


    February 2016
  34. KRISTENSEN LS, Michaelsen SR, Dyrbye H, Aslan D, et al
    Assessment of Quantitative and Allelic MGMT Methylation Patterns as a Prognostic Marker in Glioblastoma.
    J Neuropathol Exp Neurol. 2016.
    PubMed     Text format     Abstract available


  35. NOBUSAWA S, Hirato J, Sugai T, Okura N, et al
    Atypical Teratoid/Rhabdoid Tumor (AT/RT) Arising From Ependymoma: A Type of AT/RT Secondarily Developing From Other Primary Central Nervous System Tumors.
    J Neuropathol Exp Neurol. 2016;75:167-74.
    PubMed     Text format     Abstract available


    January 2016
  36. LAMA G, Mangiola A, Proietti G, Colabianchi A, et al
    Progenitor/Stem Cell Markers in Brain Adjacent to Glioblastoma: GD3 Ganglioside and NG2 Proteoglycan Expression.
    J Neuropathol Exp Neurol. 2016.
    PubMed     Text format     Abstract available


  37. VAUBEL RA, Chen SG, Raleigh DR, Link MJ, et al
    Meningiomas With Rhabdoid Features Lacking Other Histologic Features of Malignancy: A Study of 44 Cases and Review of the Literature.
    J Neuropathol Exp Neurol. 2016;75:44-52.
    PubMed     Text format     Abstract available


    December 2015
  38. TANBOON J, Williams EA, Louis DN
    The Diagnostic Use of Immunohistochemical Surrogates for Signature Molecular Genetic Alterations in Gliomas.
    J Neuropathol Exp Neurol. 2015.
    PubMed     Text format     Abstract available


  39. RICHARDSON TE, Mathis DA, Mickey BE, Raisanen JM, et al
    Clinical Outcome of Silent Subtype III Pituitary Adenomas Diagnosed by Immunohistochemistry.
    J Neuropathol Exp Neurol. 2015;74:1170-7.
    PubMed     Text format     Abstract available


  40. BROWN AF, Fan H, Floyd JR, Henry JM, et al
    Primary Central Nervous System Histiocytic Sarcoma Arising After Precursor B-Cell Acute Lymphoblastic Leukemia.
    J Neuropathol Exp Neurol. 2015;74:1120-6.
    PubMed     Text format     Abstract available


    October 2015
  41. SCHOWINSKY J, Leppert M, Ney D, Kleinschmidt-DeMasters BK, et al
    Prominent Vascular and Perivascular Eosinophilic Infiltrates Heralding CNS Mycosis Fungoides.
    J Neuropathol Exp Neurol. 2015;74:948-51.
    PubMed     Text format     Abstract available


  42. USUBALIEVA A, Pierson CR, Kavran CA, Huntoon K, et al
    Primary Meningeal Pleomorphic Xanthoastrocytoma With Anaplastic Features: A Report of 2 Cases, One With BRAF(V600E) Mutation and Clinical Response to the BRAF Inhibitor Dabrafenib.
    J Neuropathol Exp Neurol. 2015;74:960-9.
    PubMed     Text format     Abstract available


  43. GESSI M, Japp AS, Dreschmann V, Zur Muhlen A, et al
    High-Resolution Genomic Analysis of Cribriform Neuroepithelial Tumors of the Central Nervous System.
    J Neuropathol Exp Neurol. 2015;74:970-4.
    PubMed     Text format     Abstract available


    September 2015
  44. FAULKNER C, Ellis HP, Shaw A, Penman C, et al
    BRAF Fusion Analysis in Pilocytic Astrocytomas: KIAA1549-BRAF 15-9 Fusions Are More Frequent in the Midline Than Within the Cerebellum.
    J Neuropathol Exp Neurol. 2015;74:867-72.
    PubMed     Text format     Abstract available


    July 2015
  45. KAHLERT UD, Suwala AK, Koch K, Natsumeda M, et al
    Pharmacologic Wnt Inhibition Reduces Proliferation, Survival, and Clonogenicity of Glioblastoma Cells.
    J Neuropathol Exp Neurol. 2015.
    PubMed     Text format     Abstract available


  46. NIGIM F, Cavanaugh J, Patel AP, Curry WT Jr, et al
    Targeting Hypoxia-Inducible Factor 1alpha in a New Orthotopic Model of Glioblastoma Recapitulating the Hypoxic Tumor Microenvironment.
    J Neuropathol Exp Neurol. 2015;74:710-22.
    PubMed     Text format     Abstract available


  47. DRABEROVA E, D'Agostino L, Caracciolo V, Sladkova V, et al
    Overexpression and Nucleolar Localization of gamma-Tubulin Small Complex Proteins GCP2 and GCP3 in Glioblastoma.
    J Neuropathol Exp Neurol. 2015;74:723-42.
    PubMed     Text format     Abstract available


  48. BECKER AP, Scapulatempo-Neto C, Carloni AC, Paulino A, et al
    KIAA1549: BRAF Gene Fusion and FGFR1 Hotspot Mutations Are Prognostic Factors in Pilocytic Astrocytomas.
    J Neuropathol Exp Neurol. 2015;74:743-54.
    PubMed     Text format     Abstract available


    June 2015
  49. TAYLOR IC, Hutt-Cabezas M, Brandt WD, Kambhampati M, et al
    Disrupting NOTCH Slows Diffuse Intrinsic Pontine Glioma Growth, Enhances Radiation Sensitivity, and Shows Combinatorial Efficacy With Bromodomain Inhibition.
    J Neuropathol Exp Neurol. 2015.
    PubMed     Text format     Abstract available


  50. TANAHASHI K, Natsume A, Ohka F, Motomura K, et al
    Activation of Yes-Associated Protein in Low-Grade Meningiomas Is Regulated by Merlin, Cell Density, and Extracellular Matrix Stiffness.
    J Neuropathol Exp Neurol. 2015.
    PubMed     Text format     Abstract available


    May 2015
  51. REIS GF, Pekmezci M, Hansen HM, Rice T, et al
    CDKN2A loss is associated with shortened overall survival in lower-grade (World Health Organization Grades II-III) astrocytomas.
    J Neuropathol Exp Neurol. 2015;74:442-52.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: